Related Experiment Videos
[Multiple system atrophy--a neurodegenerative disease entity]
1Arhus Universitetshospital, Arhus Kommunehospital, neurologisk afdeling. helge@akhphd.au.dk
Abstract:
Multiple system atrophy (MSA) is a nosological entity. Main clinical manifestations are parkinsonism, pyramidal signs, cerebellar signs and autonomic dysfunction. Postmortem studies of patients who while alive were diagnosed as having idiopathic Parkinson's disease show approximately 8% as having MSA at autopsy. Specific pathological findings are glial cytoplasmatic inclusions. It seems likely that patients with MSA are misdiagnosed or underrecognized. This review is an attempt to elucidate upon clinical and paraclinical approaches to MSA and to depict relevant research in this field. The aetiology is unknown.
Insights
Multiple system atrophy (MSA), a neurological disorder, is often misdiagnosed. This review explores clinical approaches and research for better identification of MSA, characterized by glial cytoplasmic inclusions.
Area of Science:
- Neurology
- Pathology
Context:
- Multiple system atrophy (MSA) is a distinct neurological disorder.
- Key clinical features include parkinsonism, pyramidal and cerebellar signs, and autonomic dysfunction.
- Autopsy studies reveal MSA in approximately 8% of patients initially diagnosed with idiopathic Parkinson's disease.
Purpose:
- To review current clinical and paraclinical diagnostic approaches for MSA.
- To highlight recent research advancements in understanding MSA.
- To address the underrecognition and misdiagnosis of MSA.
Summary:
- MSA is characterized by glial cytoplasmic inclusions, a key pathological finding.
- The etiology of MSA remains unknown.
- This review synthesizes information on MSA's clinical presentation and diagnostic strategies.
Impact:
- Improved diagnostic accuracy for Multiple System Atrophy.
- Enhanced recognition of MSA in clinical practice.
- Facilitation of further research into MSA etiology and treatment.